December 16, 2008 - New data from a retrospective, multicenter, cohort study of over four million hospitalized patients shows similar unadjusted mortality rates for patients receiving DEFINITY Vial For (Perflutren Lipid Microsphere) Injectable Suspension enhanced resting echocardiography exams when compared with patients who did not receive DEFINITY.
Study findings were published in the December 2008 issue of The American Journal of Cardiology.
